Sign Out
Breastfeeding should be avoided while being treated with pms-ERLOTINIB.
Avoid pregnancy while being treated with pms-ERLOTINIB. If the patient is a woman who could become pregnant, adequate contraception must be used during treatment and for at least 2 weeks after taking the last tablet. If the patient becomes pregnant while being treated with pms-ERLOTINIB, the doctor who will decide if the treatment should be continued must be immediately informed.
